On September 28, 2015, the CMS Center for Medicare and Medicaid Innovations (CMMI) announced that it will begin testing new payment models for medication therapy management (MTM) in January 2017 for stand-alone prescription drug plans (PDPs) under the Medicare Part D program. AMCP provided a summary of CMS' requirements to participate.
Centers for Medicare and Medicaid Services (CMS) is issuing this memorandum to provide clarifying guidance to Medicare Part D plan sponsors concerning the Part D program’s any willing pharmacy (AWP) requirement.
AMCP Foundation webinar that provided insights on navigating the tight rope of Patient Cost Sharing, and explore how payers can address Value-Oriented Purchasing and Coverage